_________
false
בריינסוויי בע"מ
2
380
BRAINSWAY LTD
Corporation no:
513890764
10767
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
18/07/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-074311
Time of broadcast:
16:14
16:12:17
Amended report for distorted report sent on date
18/07/2019
Whose reference number was:
2019-02-074167
The distortion:
Addition of Graphic - Remission Response Rates for the H coil, Figure-8 coil and Medication
The distortion cause:
Addition of Graphic - Remission Response Rates for the H coil, Figure-8 coil and Medication
The main amendment:
Addition of Graphic- Remission Response Rates for the H coil, Figure-8 coil and Medication
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
_________
Groundbreaking_Study_Demonstrates_Advantages_of_BrainsWay_Deep_TMS_in_Treating_Major_Depressive_Disorder_FIG3_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
BWAY
Date of revision of form structure:
25/06/2019
Address:
הרטום
19
,
ירושלים
91451
,
Tel:
02-5813140
,
Fax:
02-5812517
E-mail address:
uri@Brainsway.com
Company site:
www.Brainsway.com
Previous names of reporting entity:
Name of the Signatory:
Levy Hadar
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Address:
Hartum Street, Bynet Building
19
,
Jerusalem
9777518
Telephone:
97225824030
Facsimile:
97225812517
E-mail:
hadarl@brainsway.com
1